Taking into account economic criterias for the clinical practice guidelines in oncology;Integration des criteres economiques dans les recommandations pour la pratique clinique en cancerologie

Bulletin du Cancer

Volumn 85, Issue 3, 1998, Pages 272-280

  Fervers, Béatrice ^a,b   Späth, Hans Martin ^a,c   Philip, Thierry ^a   Carrère, Marie Odile ^a,c  

^a CENTRE LÉON BÉRARD   (France)

^b Fed Centres Lutre Contre le Cancer   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Clinical practice guidelines; Economic evaluation; Methodology

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH ECONOMICS; MEDICAL DECISION MAKING; ONCOLOGY; PRACTICE GUIDELINE; COST; ECONOMICS; HUMAN; INFORMATION PROCESSING; NEOPLASM; STANDARD; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DATA COLLECTION; HUMANS; MEDICAL ONCOLOGY; MODELS, ECONOMETRIC; NEOPLASMS; PRACTICE GUIDELINES;

EID: 0032011452     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sournia JC, Giraud A, editor. Dictionnaire français de santé publique. Paris: Éditions de Santé, 1991.
2. American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996; 14: 671-9.
3. Browman GP. Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer. Cancer Invest 1994; 12: 662-70.
4. Mauriac L, Asselain B, Blanc-Vincent MP, Cutuli B, Dilhuydy JM, Fourquet A, et al. Standards, Options et Recommandations de la Fédération nationale des centres de lutte contre le cancer. Cancers du sein non métastatiques (vol. 3). Paris: Éditions Arnette Blackwell, 1996.
5. Agency for Health Care and Policy Research (AHCPR). McCormick KA, Moore SR, Siegel RA, editors. Clinical practice guideline development. Methodology, perspectives. Rockville: US Departement of Health and Human Services. Public Health Service, 1994.
6. Agence nationale pour le développement de l'évaluation médicale. Les recommandations pour la pratique clinique. Guide pour leur élaboration. Paris: Andem, 1993.
7. Browman GP, Levine MN, Mohide EA, Hayward RS, Pritchard KI, Gafni A, Laupacis A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995; 13: 502-12.
8. Eddy DM. Clinical decision making: from theory to practice. Connecting value and costs. Whom do we ask, and what do we ask them? JAMA 1990; 264: 1737-9.
9. Woolf SH, DiGuiseppi CG, Atkins D, Kamerow DB. Developing evidence-based clinical practice guidelines: lessons learned by the US preventive services task force. Annu Rev Public Health 1996; 17: 511-38.
10. Anderson PN. American Society of Clinical Oncology, editors. Principles of practice guidelines. Clinical practice guidelines and outcomes management: implications for oncology practices and programs, ASCO Educational Book, 1994.
11. Fettings JH. American Society of Clinical Oncology, editors. Principles of practice guidelines. Patient outcomes and guidelines. ASCO Educational Book, 1994.
12. Mulrow CD, Oxman A. Cochrane Collaboration Economics Working Group, editors. How to conduct a Cochrane systematic review? Cochrane Collaboration Handbook. Assembling information in reviews of RCTs for use in subsequent economic evaluation, San Antonio, 1997.
13. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Second edition. Oxford: Oxford University Press, 1997.
14. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medecine. New York: Oxford University Press, 1996.
15. Smith TJ, Hillner BE, Desch CE. Efficacy and cost-effectiveness of cancer treatment : rational allocation of resources based on decision analysis. J Natl Cancer Inst 1993; 85: 1460-74.
16. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995; 15: 369-90.
17. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly ? Ann Intern Med 1992; 116: 238-44.
18. Williams C, Coyle D, Gray A, Hutton J, Jefferson T, Karlsson G, et al. European School of Oncology Advisory report to the Commission of the European Communities for the «Europe Against Cancer Programme» cost-effectiveness in cancer care. Eur J Cancer 1995; 31A: 1410-24.
19. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term «cost effective» in medicine. N Engl J Med 1986; 314: 253-6.
20. Bennett CL, Armitage JL, LeSage S, Gulati SC, Armitage JO, Gorin NC. Economic analyses of clinical trials in cancer: are they helpful to policy makers ? Stem Celts (Dayt) 1994; 12: 424-9.
21. Carrère MO, Lamouliatte H, Ruszniewski P. Is eradication of Helicobacter pylori a cost-effective treatment of duodenal ulcer disease? PharmacoEconomics 1997; 11: 216-24.
22. Drummond MF, Jefferson TO. Guidelines for the authors and peer reviewers of economic submissions to the BMJ. Br Med J 1996; 313: 275-83.
23. Heyland DK, Kernerman P, Gafni A, Cook DJ. Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit? Crit Care Med 1996; 24: 1591-8.
24. Luce BR, Simpson K. Methods of cost-effectiveness analysis: areas of consensus and debate. Clin Ther 1995; 17: 109-25.
25. Jaakkimainen L, Goodwin PJ, Pater J, Warde P, Murray N, Rapp E. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. J Clin Oncol 1990; 8: 1301-9.
26. Eddy DM. Clinical decision making: from theory to practice. Anatomy of a decision. JAMA 1990; 263: 441-3.
27. Fervers B, Bonichon F, Demard F, Heron JF, Mathoulin S, Philip T, et al. Méthodologie de développement des standards, options et recommandations diagnostiques et thérapeutiques en cancérologie. Bull Cancer 1995; 82: 761-7.
28. Eddy DM. Clinical decision making: from theory to practice. Designing a practice policy. Standards, guidelines, and options. JAMA 1990; 263: 3077-84.
29. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How atttactive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992; 146: 473-81.
30. Hillner BE, Smith TJ, Desch CE. Principles of cost effectiveness analysis for the assessment of current and new therapies. J Hematother 1993; 2: 501-6.